鹿茸有效成分对小鼠肝脏RNA和蛋白质合成的影响

多次给小鼠po鹿茸多胺30mg/kg,对[³H]leucine和[³H]uridine掺入肝组织蛋白和RNA有明显的促进作用,而庸茸非多胺则无此作用;当腐胺剂量为21mg/kg时,不仅促进[³H]leucine和[³H]uridiae掺入肝组织蛋白和RNA,也促进[³H]uridine掺入肝细胞核的RNA中,并增强RNA聚合酶的活性;精脒在剂量为8mg/kg时,仅对[³H]leucine掺入肝组织蛋白有促进;而精胺在1mg/kg时,没有观察到上述各种现象。此结果提示,鹿茸多胺类物质是鹿茸中刺激小鼠肝组织蛋白和RNA合成的主要活性物质,这 种刺激小鼠肝组织蛋白和RNA合成效应是由于鹿茸多胺能够显著地增强RNA聚合酶的活性。     

Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop

We have a previously reported that interleukin-10 (IL-10) is a potent but IL-6-unrelated growth factor for freshly explanted myeloma cells (Lu et al, Blood 85:2521, 1995). We have also shown that exogenous IL- 10 supported the growth of XG-1 and XG-2 human myeloma cell lines (HMCL) through an IL-6-independent mechanism. (Lu et al, Blood 85:2521, 1995). Because the IL-10 receptor does not involve the gp 130 IL-6 transducer, we have attempted to elucidate the mechanisms of IL-10 action on myeloma cells. Our results indicate that the myeloma cell growth factor activity of IL-10 was abrogated by an antibody to the gp 130 IL-6 transducer, indicating that it was mediated through one of the gp 130-activating cytokines. We found that myeloma cells from XG-1 and XG-2 HMCL and from 5 of 6 patients' tumoral samples produced oncostatin M (OM) constitutively but failed to produce IL-6, IL-11 and leukemia- inhibitory factor (LIF). The autocrine OM was inactive in the absence of IL-10 due to lack of a functional OM receptor on myeloma cells. IL- 10, by inducing the receptor for LIF (LIFR), produced a functional autocrine OM loop in XG-1 and XG-2 cells and in primary myeloma cells from 2 patients. We also found that some myeloma cell lines (XG-4, XG- 6, and XG-7) an fresh myeloma cells from 3 of 6 patients produced an autocrine IL-10 and that these cells constitutively expressed LIFR. One HMCL (XG-7) produced IL-10, OM, and IL-6 an expressed LIFR. The XG-7 cells used OM and IL-6 as autocrine growth factors. We have previously shown that IL-10 could induce IL-11 receptor in myeloma cells and confer on them sensitivity to IL-11 (Lu et al, FEBS Lett 377:515, 1995). Taken together, these results show that IL-10 is a key cytokine for inducing the expression of LIFR and IL-11R and possibly another uncharacterized OM coreceptor on myeloma cells and that OM and IL-10 might be produced by myeloma cells. They also emphasize that all myeloma cell growth factors reported to data involve an activation of the gp130 IL-6 transducer.     

Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma

It has recently been demonstrated that interleukin-6 (IL-6) is a potent myeloma-cell growth factor in the majority of patients with multiple myeloma (MM). Using an anti-bromodeoxyuridine monoclonal antibody (MoAb) to specifically count myeloma cells in the S-phase (ie, labeling index, LI), we demonstrate that the IL-6 responsiveness of myeloma cells in vitro is directly correlated with their LI in vivo. Myeloma cells from all 13 patients with high LIs in vivo (greater than or equal to 1%) responded in vitro to IL-6, the strongest response occurring in cells from five patients with plasma-cell leukemia. In contrast, the cells of only two of eight patients with low myeloma-cell LIs in vivo (less than 1%) responded to IL-6 in vitro. After seven days of culturing with 1,000 U/mL recombinant IL-6 (rIL-6), the median LI value in the first group of patients (in vivo LI greater than or equal to 1%) was 11%, ie 11 times higher (P less than .01) than the median LI value (1%) in the second group of patients (in vivo LI less than 1%). Thus, the in vitro IL-6 responsiveness of myeloma cells is directly related to their in vivo proliferative status, and hence to the severity of the disease.     

更昔洛韦对原位肝移植术后巨细胞病毒感染的预防和治疗:19例临床资料回顾

目的:巨细胞病毒感染是器官移植后的一个严重并发症,回顾性分析肝移植术后患者巨细胞病毒感染的诊断和防治方法.方法:①回顾分析2005-05/2006-08解放军总医院第二附属医院全军器官移植中心收治的19例肝移植受者的临床资料,供者均为健康献肝者.供者、受者对治疗方案均知情同意,且得到医院伦理道德委员会批准.②术后1个月检测1次巨细胞病毒血清抗体,预防和治疗巨细胞病毒感染均采用静脉注射更昔洛韦.术后采用三联免疫抑制疗法,根据术后血药浓度及肝功能改变调整免疫抑制药物用量.③采用酶联免疫吸附法检测患者血中巨细胞病毒抗体巨细胞病毒IgG、巨细胞病毒IgM.结果:19例受者中6例发生巨细胞病毒感染,均无临床症状,并全部治愈.结论:更昔洛韦能够有效治疗肝移植术后巨细胞病毒感染.积极预防、早期治疗肝移植术后患者巨细胞病毒感染是治疗成功的关键.     

小鼠皮肤超氧化物歧化酶活性与枸杞多糖的干预

目的:观察枸杞多糖对皮肤胶原代谢和自由基产生的影响,探讨其抗皮肤衰老的作用。方法:实验于2005-06/2006-05在广东医学院整形外科研究所完成。①实验材料:清洁级昆明小鼠60只,月龄2个月,体质量16～24g,雌雄各半。②实验分组:将小鼠随机分为正常对照组、衰老模型组和抗衰老模型组,每组20只。③实验干预:模型组每日用D-半乳糖溶液皮下注射制造衰老模型,用量和时间为80mg/(kg·d)7d,120mg/(kg·d)14d,140mg/(kg·d)14d,180mg/(kg·d)7d。正常对照组每日注射同体积的生理盐水。抗衰老模型组在注射D-半乳糖期间以枸杞多糖灌胃,剂量为20mg/(kg·d),正常对照组和衰老组则以同体积的生理盐水代之灌胃。④实验评估:42d后切取小鼠颈背部皮肤,测定超氧化物歧化酶活力、羟脯氨酸和丙二醛含量。结果:56只小鼠进入结果分析(4只死亡)。①小鼠皮肤超氧化物歧化酶活力:与正常对照组相比,衰老组和抗衰老组小鼠皮肤超氧化物歧化酶活力降低,差异有显著性意义(P<0.01);抗衰老组与衰老模型组比较,超氧化物歧化酶活力增加,差异有显著性意义(P<0.01)。②与正常对照组相比,衰老组和抗衰老组小鼠皮肤羟脯氨酸和丙二醛含量增加,差异有显著性意义(P<0.01);抗衰老组与衰老组比较,羟脯氨酸和丙二醛含量均降低,差异有显著性意义(P<0.01)。结论:枸杞多糖改善皮肤老化的作用与提高小鼠皮肤超氧化物歧化酶活力,降低羟脯氨酸、丙二醛含量,影响胶原代谢有关。     

肝炎肝硬变患者血清层粘连蛋白水平与食管静脉曲张的关系

0引言食管静脉曲张破裂出血是肝硬变的严重并发症之一．近年研究表明,血清LN水平与食管静脉曲张关系密切．我们分析了108例肝炎肝硬变病例,就LN水平与食管静脉曲张程度的关系做一分析．回对象和方法1．l对象选择肝炎肝硬变连续住院患者108（男gi,女17）例,年龄43．75岁士16．92岁,慢性肝炎患者62（男sl,女11）例,年龄38．20岁士13．20岁,均测定血清1。N水平,并行电子胃镜检查．诊断标准均符合1995－05月北京第五届全国传染病和寄生虫病学术会议修订的病毒性肝炎诊断标准．1．2方法采用放射免疫法测定I。N水平;用电子胃镜确定食…     

多发性大动脉炎的麻醉

０引言多发性大动脉炎尤其侵及双侧颈总动脉、双锁骨下动脉及无名动脉罕见,我院心脏外科及血管外科近日联合手术１例该病例,现简述其麻醉特点及特殊处理．１临床资料女性,３０岁,５０ｋｇ,头晕,头昏伴心悸,出汗,双上肢冰凉,麻木,查血压右上肢０／０ｋＰａ,右下...     

幽门螺杆菌感染与胃癌发生的实验研究进展

流行病学调查显示幽门螺杆菌（Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ．Ｈｐ）感染与胃癌发生存在显著相关性，Ｈｐ感染后胃癌发生率增加４倍～９倍，且６０％胃癌患者有Ｈｐ感染．１９９４年世界卫生组织国际癌症研究机构正式将Ｈｐ列为第一类生物致癌因子．胃癌的发生是多因素共同作用的结果，包括感染、环境因素、营养状况、饮食和遗传等．目前认为Ｈｐ感染为胃癌发生的始发因素，而综合因素决定了胃癌的最后形成．一般认为Ｈｐ本身没有毒性，因此并不直接引起人体细胞ＤＮＡ突变，其确切作用环节及机制有待进一步阐明．本文就Ｈｐ感染与…     

硫酸锌对离体血管平滑肌的作用

硫酸锌是体内一种重要的微量元素,它使离体动物心脏动作电位振幅降低,有效不应期延长,并能显著降低家兔窦房结自律性。本文采用离体豚鼠胸主动脉条和犬门静脉环标本,观察硫酸锌对KCl,CaCl_2和去甲肾上腺素(NE)诱发血管平滑肌收缩的影响。进一步探讨硫酸锌与Ca~(2 )的作用关系。     

有机锗化物对豚鼠和家兔心脏电机械效应的影响

有机锗化物(二羧乙基锗三氧化物,dicarboxyethenylgermanium sesquioxide简称DCG)系一人工合成的新型化合物,分子式(GeCH_2CH_2COOH)_2O_3,分子量339.18,其中含纯锗42.8%。锗是生物体内非必需微量元素,在自然界及生物体内分布相当广泛。最近Ninomiya